Association of primary (1°) site and molecular features with progression-free survival (PFS) and overall survival (OS) of metastatic colorectal cancer (mCRC) after anti-epidermal growth factor receptor (αEGFR) therapy.Michael Sangmin Lee, Scott Kopetz, Ganiraju C. Manyam et al.|Journal of Clinical Oncology|2016Cited by 26
Distinct Patient and Tumor Characteristics of the Consensus Molecular Subtypes of Colorectal CancerJennifer S. Davis, Scott Kopetz, Ruoxi Yu et al.|Gastroenterology|2017Cited by 2